213 related articles for article (PubMed ID: 21062985)
1. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma.
Diegel CR; Cho KR; El-Naggar AK; Williams BO; Lindvall C
Cancer Res; 2010 Nov; 70(22):9143-52. PubMed ID: 21062985
[TBL] [Abstract][Full Text] [Related]
2. Cooperation Between Pten and Smad4 in Murine Salivary Gland Tumor Formation and Progression.
Cao Y; Liu H; Gao L; Lu L; Du L; Bai H; Li J; Said S; Wang XJ; Song J; Serkova N; Wei M; Xiao J; Lu SL
Neoplasia; 2018 Aug; 20(8):764-774. PubMed ID: 29958137
[TBL] [Abstract][Full Text] [Related]
3. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.
Ding L; Han L; Li Y; Zhao J; He P; Zhang W
Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
[TBL] [Abstract][Full Text] [Related]
4. Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma.
Kong B; Cheng T; Qian C; Wu W; Steiger K; Cao J; Schlitter AM; Regel I; Raulefs S; Friess H; Erkan M; Esposito I; Kleeff J; Michalski CW
Mol Cancer; 2015 Dec; 14():212. PubMed ID: 26683340
[TBL] [Abstract][Full Text] [Related]
5. High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy.
Liu H; Du L; Wang R; Wei C; Liu B; Zhu L; Liu P; Liu Q; Li J; Lu SL; Xiao J
Oncotarget; 2015 May; 6(13):11477-91. PubMed ID: 25909167
[TBL] [Abstract][Full Text] [Related]
6. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
[TBL] [Abstract][Full Text] [Related]
7. EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas.
Suzuki S; Dobashi Y; Minato H; Tajiri R; Yoshizaki T; Ooi A
Virchows Arch; 2012 Sep; 461(3):271-82. PubMed ID: 22828828
[TBL] [Abstract][Full Text] [Related]
8. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway.
Goyal B; Duncavage EJ; Martinez D; Lewis JS; Chernock RD
Exp Mol Pathol; 2014 Dec; 97(3):572-8. PubMed ID: 25446844
[TBL] [Abstract][Full Text] [Related]
10. Implications of methylation patterns of cancer genes in salivary gland tumors.
Williams MD; Chakravarti N; Kies MS; Maruya S; Myers JN; Haviland JC; Weber RS; Lotan R; El-Naggar AK
Clin Cancer Res; 2006 Dec; 12(24):7353-8. PubMed ID: 17189407
[TBL] [Abstract][Full Text] [Related]
11. Secretory carcinoma of the breast: a tumour analogous to salivary gland acinic cell carcinoma?
Hirokawa M; Sugihara K; Sai T; Monobe Y; Kudo H; Sano N; Sano T
Histopathology; 2002 Mar; 40(3):223-9. PubMed ID: 11895487
[TBL] [Abstract][Full Text] [Related]
12. mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.
Boudra R; Lagrafeuille R; Lours-Calet C; de Joussineau C; Loubeau-Legros G; Chaveroux C; Saru JP; Baron S; Morel L; Beaudoin C
Cell Cycle; 2016 May; 15(10):1352-62. PubMed ID: 27050906
[TBL] [Abstract][Full Text] [Related]
13. Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Lee YH
Virchows Arch; 2019 Nov; 475(5):617-624. PubMed ID: 31187185
[TBL] [Abstract][Full Text] [Related]
14. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
15. Acinic cell carcinoma of the breast: A comprehensive review.
Ajkunic A; Skenderi F; Shaker N; Akhtar S; Lamovec J; Gatalica Z; Vranic S
Breast; 2022 Dec; 66():208-216. PubMed ID: 36332545
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mammalian target of rapamycin with rapamycin reverses hypertrophic cardiomyopathy in mice with cardiomyocyte-specific knockout of PTEN.
Xu X; Roe ND; Weiser-Evans MC; Ren J
Hypertension; 2014 Apr; 63(4):729-39. PubMed ID: 24446058
[TBL] [Abstract][Full Text] [Related]
17. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
Meer S; Altini M
Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
[TBL] [Abstract][Full Text] [Related]
18. mTOR activation in immature cells of primary nasopharyngeal carcinoma and anti-tumor effect of rapamycin in vitro and in vivo.
Yang C; Peng J; Jiang W; Zhang Y; Chen X; Wu X; Zhu Y; Zhang H; Chen J; Wang J; Cho WC; Jin K
Cancer Lett; 2013 Dec; 341(2):186-94. PubMed ID: 23933173
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN.
Tanwar PS; Zhang L; Kaneko-Tarui T; Curley MD; Taketo MM; Rani P; Roberts DJ; Teixeira JM
PLoS One; 2011; 6(6):e20715. PubMed ID: 21695255
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland.
Heikinheimo KA; Laine MA; Ritvos OV; Voutilainen RJ; Hogan BL; Leivo IV
Cancer Res; 1999 Nov; 59(22):5815-21. PubMed ID: 10582704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
